Pregabalin 300 mg vs placebo
Participant‐reported pain relief of 30% or greater · adults with moderate or severe pain associated with postherpetic neuralgia
1 finding from 1 review
- no estimate extracted3 studies · 589 participantsModerate
Findings
What do systematic reviews say?
6 questions · 6 findings · 3 reviews · Pain, Palliative and Supportive Care
No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 5 · 83.3%High 1 · 16.7%
Pregabalin 300 mg vs placebo
Participant‐reported pain relief of 30% or greater · adults with moderate or severe pain associated with painful diabetic neuropathy
1 finding from 1 review
- no estimate extracted8 studies · 2320 participantsModerate
Pregabalin 600 mg vs placebo
Participant‐reported pain relief of 30% or greater · adults with moderate or severe pain associated with painful diabetic neuropathy
1 finding from 1 review
- no estimate extracted3 studies · 789 participantsModerate
Pregabalin 600 mg vs placebo
Participant‐reported pain relief of 30% or greater · adults with moderate or severe pain associated with postherpetic neuralgia
1 finding from 1 review
- no estimate extracted3 studies · 537 participantsModerate
Gabapentin vs placebo
Moderate benefit: At least 30% reduction in pain, or PGIC much or very much improved · people with diabetic peripheral neuropathy
1 finding from 1 review
- no estimate extracted7 studies · 1439 participantsModerate
Pregabalin vs placebo
Maintenance of initial therapeutic response of at least 30% pain intensity reduction over baseline and continued treatment at 13 or 26 weeks (equivalent to 'moderate benefit') · adults with fibromyalgia enrolled in EERW studies
1 finding from 1 review
- no estimate extracted2 studies · 687 participantsHigh